[
1. E. Dong, H. Du and L. Gardner, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect. Dis. 20(5) (2020) 533–534; https://doi.org/10.1016/S1473-3099(20)30120-110.1016/S1473-3099(20)30120-1
]Search in Google Scholar
[
2. M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, T. S. Schiergens, G. Herrler, N.-H. Wu, A. Nitsche, M. A. Müller, C. Drosten and S. Pöhlmann, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, 181(2) Cell (2020) 271–280; https://doi.org/10.1016/j.cell.2020.02.05210.1016/j.cell.2020.02.052
]Search in Google Scholar
[
3. L. K. Gadanec, K. R. McSweeney, T. Qaradakhi, B. Ali, A. Zulli and V. Apostolopoulos, Can SARSCoV-2 virus use multiple receptors to enter host cells?, Int. J. Mol. Sci. 22(3) (2021) Article ID 992 (36 pages); https://doi.org/10.3390/ijms2203099210.3390/ijms22030992
]Search in Google Scholar
[
4. C. G. Benítez-Cardoza and J. L. Vique-Sánchez, Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug, Life Sci. 256 (2020) Article ID 117970; https://doi.org/10.1016/j.lfs.2020.11797010.1016/j.lfs.2020.117970
]Search in Google Scholar
[
5. S. M. Kishk, R. M. Kishk, A. S. A. Yassen, M. S. Nafie, N. A. Nemr, G. ElMasry, S. Al-Rejaie and C. Simons, Molecular insights into human transmembrane protease serine-2 (TMPS2) inhibitors against SARS-CoV2: Homology modelling, molecular dynamics, and docking studies, Molecules 25(21) (2020) Article ID 5007 (16 pages); https://doi.org/10.3390/molecules2521500710.3390/molecules25215007
]Search in Google Scholar
[
6. J. L. Vique-Sánchez, Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking, Bioorg. Med. Chem. 33 (2021) Article ID 116040; https://doi.org/10.1016/j.bmc.2021.11604010.1016/j.bmc.2021.116040
]Search in Google Scholar
[
7. Y. Choi, B. Shin, K. Kang, S. Park and B. R. Beck, Target-centered drug repurposing predictions of human angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine subtype 2 (TMPRSS2) interacting approved drugs for coronavirus disease 2019 (COVID-19) treatment through a drug-target interaction deep learning model, Viruses 12(11) (2020) Article ID 1325 (11 pages); https://doi.org/10.3390/v12111325
]Search in Google Scholar
[
8. S. Wang, Z. Qiu, Y. Hou, X. Deng, W. Xu, T. Zheng, P. Wu, S. Xie, W. Bian, C. Zhang, Z. Sun, K. Liu, C. Shan, A. Lin, S. Jiang, Y. Xie, Q. Zhou, Lu Lu, J. Huang and Xu Li, AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells, Cell Res. 31 (2021) 126–140; https://doi.org/10.1038/s41422-020-00460-y10.1038/s41422-020-00460-y
]Search in Google Scholar
[
9. C. Xu, A. Wang, Ke Geng, W. Honnen, X. Wang, N. Bruiners, S. Singh, F. Ferrara, S. D’Angelo, A. R. M. Bradbury, M. L. Gennaro, D. Liu, A. Pinter and T. L. Chang, Human immunodeficiency viruses pseudotyped with SARS-CoV-2 spike proteins infect a broad spectrum of human cell lines through multiple entry mechanisms, Viruses 13(6) (2021) Article ID 953 (17 pages); https://doi.org/10.3390/v1306095310.3390/v13060953
]Search in Google Scholar
[
10. C. Lai and G. Lemke, An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system, Neuron 6 (1991) 691–704; https://doi.org/10.1016/0896-6273(91)90167-X10.1016/0896-6273(91)90167-X
]Search in Google Scholar
[
11. Y. Tian, Z. Zhang, L. Miao, Z. Yang, J. Yang, Y. Wang, D. Qian, H. Cai and Y. Wang, Anexelekto (AXL) increases resistance to EGFR-TKI and activation of AKT and ERK1/2 in non-small cell lung cancer cells, Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 24 (2016) 295–303; https://doi.org/10.3727/09650401614648701447814
]Search in Google Scholar
[
12. T. Pillaiyar and S. Laufer, Kinases as potential therapeutic targets for anti-coronaviral therapy, J. Med. Chem. (2021) in press; https://doi.org/10.1021/acs.jmedchem.1c0033510.1021/acs.jmedchem.1c00335818904434081439
]Search in Google Scholar
[
13. J. Huckriede, S. B. Anderberg, A. Morales, F. de Vries, M. Hultström, A. Bergqvist, J. T. Ortiz-Pérez, J. W. Sels, K. Wichapong, M. Lipcsey, M. van de Poll, A. Larsson, T. Luther, C. Reutelingsperger, P. G. de Frutos, R. Frithiof and G. A. F. Nicolaes, Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients, Sci. Rep. 11 (2021) Article ID 15701 (12 pages); https://doi.org/10.1038/s41598-021-95209-x10.1038/s41598-021-95209-x833332134344929
]Search in Google Scholar
[
14. J. Dai, X. Teng, S. Jin and Y. Wu, The antiviral roles of hydrogen sulfide by blocking the interaction between SARS-CoV-2 and its potential cell surface receptors, Oxid. Med. Cell. Longev. 2021 (2021) Article ID 7866992 (11 pages); https://doi.org/10.1155/2021/786699210.1155/2021/7866992842116134497683
]Search in Google Scholar
[
15. M. S. Kariolis, Y. R. Miao, A. Diep, S. E. Nash, M. M. Olcina, D. Jiang, D. S. Jones II, S. Kapur, I. I. Mathews, A. C. Koong, E. B. Rankin, J. R. Cochran and A. J. Giaccia, Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies, J. Clin. Invest. 127(1) (2016) 183–198; https://doi.org/10.1172/JCI8561010.1172/JCI85610519971627893463
]Search in Google Scholar
[
16. S. H. Chung, J. Park, J. W. Lee, J. Song, D. Jung and K. H. Min, Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors, J. Enzyme Inhib. Med. Chem. 35(1) (2020) 1822–1833; https://doi.org/10.1080/14756366.2020.182540710.1080/14756366.2020.1825407753438332972253
]Search in Google Scholar
[
17. M. L. Lotsberg, K. Wnuk-Lipinska, S. Terry, T. Z. Tan, N. Lu, L. Trachsel-Moncho, G. V. Røsland, M. I. Siraji, M. Hellesøy, A. Rayford, K. Jacobsen, H. J. Ditzel, O. K. Vintermyr, T. G. Bivona, J. Minna, R. A. Brekken, B. Baguley, D. Micklem, L. A. Akslen, G. Gausdal, A. Simonsen, J. P. Thiery, S. Chouaib, J. B. Lorens and A. S. Tenfjord Engelsen, AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells, J. Thorac. Oncol. 15(6) (2020) 973–999; https://doi.org/10.1016/j.jtho.2020.01.01510.1016/j.jtho.2020.01.015739755932018052
]Search in Google Scholar
[
18. A. Tutusaus, M. Marí, J. T. Ortiz-Pérez, G. A. F. Nicolaes, A. Morales and P. García de Frutos, Role of vitamin K-dependent factors protein S and GAS6 and TAM receptors in SARS-CoV-2 infection and COVID-19-associated immunothrombosis, Cells 9(10) (2020) ID 2186 (15 pages); https://doi.org/10.3390/cells910218610.3390/cells9102186760176232998369
]Search in Google Scholar
[
19. S. N. Batchu, J. Xia, K. A. Ko, M. M. Doyley, J.-I. Abe, C. N. Morrell and V. A. Korshunov, Axl modulates immune activation of smooth muscle cells in vein graft remodeling, Am. J. Physiol. Circ. Physiol. 309(6) (2015) H1048–H1058; https://doi.org/10.1152/ajpheart.00495.201510.1152/ajpheart.00495.2015459136026276821
]Search in Google Scholar
[
20. M. Tanaka and D. W. Siemann, Axl signaling is an important mediator of tumor angiogenesis, Oncotarget 10(30) (2019) 2887–2898; https://doi.org/10.18632/oncotarget.2688210.18632/oncotarget.26882649959731080559
]Search in Google Scholar
[
21. C. A. Stewart, C. M. Gay, K. Ramkumar, K. R. Cargill, R. J. Cardnell, M. B. Nilsson, S. Heeke, E. M. Park, S. T. Kundu, L. Diao, Q. Wang, L. Shen, Y. Xi, B. Zhang, C. M. Della Corte, Y. Fan, K. Kundu, B. Gao, K. Avila, C. R. Pickering, F. M. Johnson, J. Zhang, H. Kadara, J. D. Minna, D. L. Gibbons, J. Wang, J. V. Heymach and L. Averett Byers, Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology, bioRxiv preprint posted January 28, 2021; https://doi.org/10.1101/2020.05.28.12229110.1101/2020.05.28.122291730220632577652
]Search in Google Scholar
[
22. M. Bouhaddou, D. Memon, B. Meyer, K. M. White, V. V. Rezelj, M. Correa Marrero, B. J. Polacco, J. E. Melnyk, S. Ulferts, R. M. Kaake, J. Batra, A. L. Richards, E. Stevenson, D. E. Gordon, A. Rojc, K. Obernier, J. M. Fabius, M. Soucheray, L. Miorin, E. Moreno, C. Koh, Q. D. Tran, A. Hardy, R. Robinot, T. Vallet, B. E. Nilsson-Payant, C. Hernandez-Armenta, A. Dunham, S. Weigang, J. Knerr, M. Modak, D. Quintero, Y. Zhou, A. Dugourd, A. Valdeolivas, T. Patil, Q. Li, R. Hüttenhain, M. Cakir, M. Muralidharan, M. Kim, G. Jang, B. Tutuncuoglu, J. Hiatt, J. Z. Guo, J. Xu, S. Bouhaddou, C. J. P. Mathy, A. Gaulton, E. J. Manners, E. Félix, Y. Shi, M. Goff, J. K. Lim, T. McBride, M. C. O’Neal, Y. Cai, J. C. J. Chang, D. J. Broadhurst, S. Klippsten, E. De Wit, A. R. Leach, T. Kortemme, B. Shoichet, M. Ott, J. Saez-Rodriguez, B. R. tenOever, R. D. Mullins, E. R. Fischer, G. Kochs, R. Grosse, A. García-Sastre, M. Vignuzzi, J. R. Johnson, K. M. Shokat, D. L. Swaney, P. Beltrao and N. J. Krogan, The global phosphorylation landscape of SARS-CoV-2 infection, Cell 182(3) (2020) 685–712; https://doi.org/10.1016/j.cell.2020.06.03410.1016/j.cell.2020.06.034732103632645325
]Search in Google Scholar
[
23. C. G. Benítez-Cardoza, L. G. Brieba, R. Arroyo, A. Rojo-Domínguez and J. L. Vique-Sánchez, Triose-phosphate isomerase as a therapeutic target against trichomoniasis, Mol. Biochem. Parasitol. 246 (2021) Article ID 111413; https://doi.org/10.1016/j.molbiopara.2021.11141310.1016/j.molbiopara.2021.111413
]Search in Google Scholar
[
24. ChemBridge Corp., EXPRESS-Pick Stock, https://chembridge.com/screening_libraries/#EXPRESSPick; last acces date November 10, 2020
]Search in Google Scholar
[
25. C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 23(1–3) (1997) 3–25; https://doi.org/10.1016/S0169-409X(96)00423-110.1016/S0169-409X(96)00423-1
]Search in Google Scholar
[
26. Advanced Chemistry Development, Inc., PhysChem, ADME & Toxicity, Version 2021.1.1, Toronto (ON, Canada) 2021; www.acdlabs.com; last access date September 15, 2021
]Search in Google Scholar
[
27. J. Dong, N.-N. Wang, Z.-J. Yao, L. Zhang, Y. Cheng, D. Ouyang, A.-P. Lu and D.-S. Cao, ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database, J. Cheminform. 10 (2018) Article ID 29 (11 pages); https://doi.org/10.1186/s13321-018-0283-x10.1186/s13321-018-0283-x602009429943074
]Search in Google Scholar
[
28. P. Banerjee, A. O. Eckert, A. K. Schrey and R. Preissner, ProTox-II: a webserver for the prediction of toxicity of chemicals, Nucleic Acids Res. 46(W1) (2018) W257–W263; https://doi.org/10.1093/nar/gky31810.1093/nar/gky318603101129718510
]Search in Google Scholar
[
29. X. Chi, R. Yan, J. Zhang, G. Zhang, Y. Zhang, M. Hao, Z. Zhang, P. Fan, Y. Dong, Y. Yang, Z. Chen, Y. Guo, J. Zhang, Y. Li, X. Song, Y. Chen, L. Xia, L. Fu, L. Hou, J. Xu, C. Yu, J. Li, Q. Zhou and W. Chen, A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2, Science 369(6504) (2020) 650–655; https://doi.org/10.1126/science.abc695210.1126/science.abc6952731927332571838
]Search in Google Scholar
[
30. C. V. Rothlin, E. A. Carrera-Silva, L. Bosurgi and S. Ghosh, TAM receptor signaling in immune homeostasis, Annu. Rev. Immunol. 33 (2015) 355–391; https://doi.org/10.1146/annurev-immunol-032414-11210310.1146/annurev-immunol-032414-112103449191825594431
]Search in Google Scholar